Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Chlorination-Driven BODIPY Fluorescent Probes for the Selective Monitoring of Myeloperoxidase Activity in Cells and Inflamed Mouse Models.

Created on 17 Sep 2026

Authors

Siyoung Cho, Yongyang Luo, Jeehyeon Bae, Youngmi Kim

Published in

Angewandte Chemie (International ed. in English). Pages e9709775. Sep 16, 2026. Epub Sep 16, 2026.

Abstract

Myeloperoxidase (MPO) generates hypochlorous acid (HOCl), a major oxidant in inflammatory biology and an increasingly recognized pathogenic mediator and therapeutic target in oxidative and inflammatory diseases. However, selective detection of MPO activity remains challenging because most HOCl-responsive fluorescent probes operate through nonspecific oxidative mechanisms, rendering them vulnerable to interference from competing reactive oxygen and nitrogen species. Here, we present an MPO-reporting fluorescent platform based on a meso-carboxamide-substituted 3,5-dimethyl BODIPY scaffold that exploits the electrophilic chlorinating reactivity of MPO-derived HOCl. The lead probe undergoes rapid chlorination at the 2,6-positions, generating highly emissive products with ca. 40 nm bathochromic shifts and overcoming the minimal spectral responses and fluorescence quenching that have limited earlier chlorination-based designs. The modular meso-carboxamide architecture further allows facile incorporation of targeting motifs without compromising probe performance. This platform enables quantitative MPO assays, cellular imaging of exogenous and endogenous MPO-derived HOCl, discrimination between cancer and normal cells based on redox differences, and noninvasive visualization of MPO-driven inflammation in a mouse model of atopic dermatitis. These results establish electrophilic chlorination as a viable design strategy for selective MPO-responsive fluorescent probes and provide a versatile tool for investigating MPO-associated inflammatory pathophysiology in biological and preclinical disease models.

PMID:
42747768
Bibliographic data and abstract were imported from PubMed on 17 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement